Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene

The vaccinia virus (VV) E3L gene, which encodes a potent inhibitor of the interferon (IFN)-induced, double-stranded RNA (dsRNA)-dependent protein kinase, PKR, is thought to be involved in the IFN-resistant phenotype of VV. The E3L gene products, p25 and p20, act as inhibitors of PKR, presumably by binding and sequestering activator dsRNA from the kinase. In this study we demonstrate that VV with the E3L gene specifically deleted (vP1080) was sensitive to the antiviral effects of IFN and debilitated in its ability to rescue vesicular stomatitis virus from the antiviral effects of IFN. Infection of L929 cells with E3L-minus virus led to rRNA degradation typical of activation of the 2'-5'-oligoadenylate synthetase/RNase L system, and extracts of infected cells lacked the PKR-inhibitory activity characteristic of wild-type VV. The reovirus S4 gene, which encodes a dsRNA-binding protein (sigma 3) that can also inhibit PKR activation by binding and sequestering activator dsRNA, was inserted into vP1080. The resultant virus (vP1112) was partially resistant to the antiviral effects of IFN in comparison with vP1080. Further studies demonstrated that transient expression of the reovirus sigma 3 protein rescued E3L-minus VV replication in HeLa cells. In these studies, rescue by sigma 3 mutants correlated with their ability to bind dsRNA. Finally, vP112 was also able to rescue the replication of the IFN-sensitive virus vesicular stomatitis virus in a manner similar to that of wild-type VV. Together, these results suggest that the reovirus S4 gene can replace the VV E3L gene with respect to interference with the IFN-induced antiviral activity.

[1]  E. Paoletti,et al.  Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon , 1991 .

[2]  M. Perkus,et al.  Methodology of using vaccinia virus to express foreign genes in tissue culture , 1993 .

[3]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[4]  J. Youngner,et al.  Sensitivity of Ribonucleic Acid and Deoxyribonucleic Acid Viruses to Different Species of Interferon in Cell Cultures , 1972, Journal of virology.

[5]  M. Berry,et al.  Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts. , 1986, Methods in enzymology.

[6]  C. Samuel,et al.  Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region , 1992, Journal of virology.

[7]  P. Whitaker-Dowling,et al.  Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon. , 1986, Virology.

[8]  I. Kerr,et al.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Jagus,et al.  Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. , 1989, The Journal of biological chemistry.

[10]  P. Whitaker-Dowling,et al.  Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. , 1984, Virology.

[11]  J. Kahn,et al.  A mutation of the nucleoside triphosphate phosphohydrolase I (NPH-I) gene confers sensitivity of vaccinia virus to interferon. , 1993, Virology.

[12]  A. Shatkin,et al.  Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.

[13]  A. Hovanessian,et al.  Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.

[14]  B. Moss,et al.  Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. , 1993, Virology.

[15]  I. Kerr,et al.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. , 1981, Nucleic acids research.

[16]  H. W. Chang,et al.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. , 1991, Virology.

[17]  R. Condit,et al.  Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA , 1990, Journal of virology.

[18]  P. Lengyel,et al.  Interferon, double-stranded RNA and mRNA degradation , 1976, Nature.

[19]  S. Goebel,et al.  Vaccinia virus host range genes. , 1990, Virology.

[20]  M. Esteban,et al.  Vaccinia virus nucleoside triphosphate phosphohydrolase I controls early and late gene expression by regulating the rate of transcription , 1993, Journal of virology.

[21]  B. Jacobs,et al.  Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Robert E. Kingston (CsCl isolation),et al.  Guanidinium Methods for Total RNA Preparation , 1991, Current protocols in molecular biology.

[23]  P. Whitaker-Dowling,et al.  Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity. , 1983, Virology.

[24]  M. Roner,et al.  Reovirus RNA is infectious. , 1990, Virology.

[25]  G. Smith.  Vaccinia virus glycoproteins and immune evasion. The sixteenth Fleming Lecture. , 1993, The Journal of general virology.

[26]  B. Williams,et al.  Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts , 1978, Cell.

[27]  R. Condit,et al.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. , 1993, Virology.

[28]  W. K. Roberts,et al.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication , 1984, Journal of virology.

[29]  M. Perkus,et al.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system , 1989, Journal of virology.

[30]  H. W. Chang,et al.  The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms , 1993, Journal of virology.

[31]  W. Joklik,et al.  Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. , 1976, Virology.

[32]  R. Drillien,et al.  Host range deletion mutant of vaccinia virus defective in human cells. , 1981, Virology.

[33]  D. Spehner,et al.  A cowpox virus gene required for multiplication in Chinese hamster ovary cells , 1988, Journal of virology.

[34]  V. Pathak,et al.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs , 1989, Molecular and cellular biology.

[35]  M. Perkus,et al.  NYVAC: a highly attenuated strain of vaccinia virus. , 1992, Virology.

[36]  H. W. Chang,et al.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Esteban,et al.  Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. , 1984, Virology.

[38]  R. Condit,et al.  Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus , 1989, Journal of virology.

[39]  M. Katze.  Games viruses play: a strategic initiative against the interferon-induced dsRNA activated 68,000 Mr protein kinase , 1993 .

[40]  M. Esteban,et al.  Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2'p)nA-synthetase. , 1984, Virology.

[41]  B. Safer.  2B or not 2B: Regulation of the catalytic utilization of elF-2 , 1983, Cell.

[42]  I. Kerr,et al.  Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells , 1984, Journal of virology.

[43]  B. Jacobs,et al.  Site-Directed Mutagenic Analysis of Reovirus σ3 Protein Binding to dsRNA , 1994 .